The legacy success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily reliant on biosimilars and the diminishing patent protection surrounding this https://socialbraintech.com/story6378027/the-blue-pill-and-drugmakers-a-risky-investment